Russell Frank Company’s Abiomed Inc ABMD Stock Holding History

Russell Frank Company’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$14.1M	Sell	148,203 -122,008	-45%	-$10.3M	0.02%	759
2015 Q4	$24.9M	Buy	270,211 +56,154	+26%	+$4.77M	0.04%	473
2015 Q3	$19.9M	Sell	214,057 -102,519	-32%	-$9.03M	0.04%	548
2015 Q2	$20.8M	Buy	316,576 +75,845	+32%	+$5.04M	0.03%	599
2015 Q1	$17.2M	Sell	240,731 -48,799	-17%	-$2.65M	0.03%	642
2014 Q4	$11.1M	Sell	289,530 -29,810	-9%	-$940K	0.02%	850
2014 Q3	$7.93M	Buy	319,340 +59,154	+23%	+$1.5M	0.01%	1012
2014 Q2	$6.66M	Buy	260,186 +89,968	+53%	+$2.09M	0.01%	1161
2014 Q1	$4.18M	Buy	170,218 +25,777	+18%	+$713K	0.01%	1386
2013 Q4	$3.97M	Sell	144,441 -50,004	-26%	-$1.24M	0.01%	1355
2013 Q3	$3.71M	Sell	194,445 -7,401	-4%	-$169K	0.01%	1510
2013 Q2	$4.35M	Buy	+201,846	New	+$4.06M	0.01%	1323

Other funds holding ABMD

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

EWM

Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Russell Frank Company's ABMD Position: Q1 2016 in Review

Russell Frank Company reduced its Abiomed Inc (ABMD) stake by 45% in Q1 2016, selling an estimated $10.3M and leaving 148,203 shares worth $14.1M. The position accounts for 0.02% of the portfolio, ranked #759.

Russell Frank Company first reported a position in ABMD in Q2 2013 and has held it in 12 quarters since. The position peaked at $24.9M in Q4 2015. 274 funds tracked by Wall St. Rank hold ABMD as of Q1 2016.

Russell Frank Company held 148,203 shares of Abiomed Inc worth $14.1M as of Q1 2016.
Russell Frank Company sold 122,008 Abiomed Inc shares in Q1 2016, an estimated $10.3M.
Abiomed Inc made up 0.02% of Russell Frank Company's portfolio in Q1 2016, its #759 holding.
Russell Frank Company first reported a position in Abiomed Inc in Q2 2013 and has held it in 12 quarters since.
Russell Frank Company's Abiomed Inc position peaked at $24.9M in Q4 2015.
274 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2016.

Based on Russell Frank Company's 13F filing for Q1 2016, filed 29 Apr 2016.